We’re Indero. A clinical trial delivery partner for immune-mediated diseases. Every therapy deserves a champion. Meet yours.
STOP THE NOISE!
Monday, November 9th
7:00 to 9:00 AM
Orlando, Florida
During ACR Convergence 2026!
Dr. Andreas Kerschbaumer will present on placebo response in PsA and RA trials, Dr. Joan T. Merrill on the challenge in SLE trials. They will be joined at the roundtable with Indero’s Senior Director, Rheumatology, Dr. Juan Ovalles, and Pina D’Angelo, Global Head, Data, Medical & Regulatory Sciences, Indero.
Come for the science, and start your ACR Convergence day with a hearty breakfast and bottomless coffee!
For over two decades, Innovaderm has been the leading dermatology CRO and one of the largest dermatology Clinical Research Units (CRU) in North America. As we continue to grow and support immune-mediated diseases—including those in rheumatology, a therapeutic area inextricably linked to dermatology—we have rebranded the CRO side of our business to Indero. Our CRU will retain the name Innovaderm and will continue to conduct dermatology studies.
Indero offers clinical trial delivery solutions for dermatology and rheumatology, covering both early and late phase trials. Our integrated and targeted services span the world, with capabilities in North America, Europe, Latin America, and Asia-Pacific. Leveraging our relationships with investigators globally, we excel in addressing the unmet needs of immune-mediated disease studies worldwide.
Head of Clinical Operations
“Working with Indero for our alopecia areata trial has been a smooth and exceptional experience, marked by their extensive expertise, proactive approach, and seamless collaboration.”
Indero’s dual-focus, interdisciplinary approach allows us to support clinical studies for a wide range of dermatology and rheumatology conditions.
Formerly known as Innovaderm, Indero is a world-renowned expert and clinical research leader in dermatology. We have more than two decades of experience serving a broad range of indications, patient populations, administration routes, and drug classes, and a global footprint.
Years of Experience
Clinical Trials
Investigators
Indications
Indero offers a full-service approach for rheumatology, which includes everything from protocol design to data delivery. We provide biotech and pharmaceutical sponsors with the rigorous scientific foundation and tailored expertise their studies need to reach the finish line efficiently and effectively.
Years of Experience
Investigators
Indications
Rheumatoid arthritis (RA)
Systemic sclerosis / Scleroderma
Osteoarthritis (OA)
Psoriatic arthritis (PsA)
Systemic lupus erythematosus (SLE) and juvenile SLE
Lupus nephritis
Osteoporosis
Idiopathic inflammatory myopathies (IIM), including polymyositis (PM) and dermatomyositis (DM)
Radiographic (ankylosing spondylitis) and non-radiographic axial spondyloarthritis (nr-axSpA)
Sjögren’s disease
Indero brings 25+ years’ experience in clinical research and trial delivery. Our full-service, value-added approach provides biotech and pharmaceutical sponsors with the rigorous scientific foundation and tailored expertise their studies need to reach the finish line.
Wherever
You’re Going,
We’re all in.
Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.
Fields marked with * are required.
